UgenTec

About:

UgenTec delivers an independent diagnostic platform to help molecular labs with their DNA (PCR) analyses.

Twitter/X: ugentec

Top Investors: imec, EASME - EU Executive Agency for SMEs, EIT Digital Accelerator, Limburgse Reconversie Maatschappij, KU Leuven

Description:

Located on the Corda Campus in Hasselt and actively supported by iMinds and EIT-ICT labs, UgenTec is one of the fastest growing companies of the region. We received multiple awards and scientific and innovation recognitions for our innovative market approach and our paradigm-shifting algorithm innovations. UgenTec delivers an independent diagnostic platform to help molecular labs with their DNA (PCR) analyses. For every real-time PCR device we can perform a standardized, automated and certified interpretation of all PCR assays. Without additional training a lab technician can reduce the analysis time of a sample set from 1.5 hours to 3 minutes and this with a higher reliability. Thus we spectacularly improve the efficiency of labs and provide the patient with a higher diagnostic certainty.

Total Funding Amount:

11.2M EUR

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Hasselt, Limburg, Belgium

Founded Date:

2014-01-01

Contact Email:

info(AT)ugentec.com

Founders:

Tom Martens, Wouter Uten

Number of Employees:

11-50

Last Funding Date:

2018-03-29

IPO Status:

Private

Industries: